Unicef

WHO adds MVA-BN vaccine to prequalification list for Mpox, aiming to increase access and contain outbreaks. The vaccine, administered in 2 doses, can be kept at 2–8°C for up to 8 weeks and is recommended for high-risk individuals. WHO emphasizes the need for equitable access and data collection on vaccine safety and effectiveness.

WHO approves MVA-BN as the first mpox vaccine on its pre-qualification list, effective at 82% with two doses. The vaccine is recommended for those over 18, with potential off-label use in younger and vulnerable groups. WHO aims to accelerate global access to the vaccine amid ongoing outbreaks.

WHO prequalifies MVA-BN vaccine for mpox, facilitating access to reduce transmission. Recommended for high-risk individuals, it can be used off-label in children, pregnant women, and immunocompromised people. Single-dose use is advised in supply-constrained situations. WHO emphasizes data collection on safety and effectiveness, with ongoing assessments for other mpox vaccines.

WHO announced MVA-BN vaccine as the first mpox vaccine on its prequalification list, aiming to facilitate timely access and reduce transmission. The vaccine, administered in two doses four weeks apart, can be stored at 2-8°C for up to eight weeks. WHO Director-General Tedros Adhanom Ghebreyesus emphasized the need for urgent scale-up in procurement and rollout for equitable access.

Bavarian Nordic A/S faces pressure to lower its mpox vaccine price for Africa, currently at $100-$141 per dose, as talks with agencies like Unicef aim to secure 12 million doses by 2025. Critics argue the high cost is prohibitive for African nations dealing with multiple health crises, urging discounts or generic production. Bavarian Nordic acknowledges pricing challenges but seeks a balance to ensure vaccine availability.

Women face high risk in first 48 hours after seeking protection from family violence; pregnant women rely on older drugs vulnerable to supply chain disruptions; tourism industry faces climate crisis threats; Paris Paralympics conclude with a stunning closing ceremony; Sudan's ongoing war receives limited global attention; intervention order system for domestic violence needs reform; Guy Montgomery shares three useful objects; NSW considers banning helium balloons and reusable cups; final report of the royal commission into defence and veteran suicide to be handed down.

CSOs warn Uganda must address vaccine access and distribution to manage mpox outbreak from DRC, where clade Ib variant has infected 19,900 and killed 975. Uganda confirmed 10 cases, with concerns over cross-border spread. International organizations scramble to secure 12 million vaccine doses for Africa, but supply chains are strained, costs are high, and regulatory delays stall rollout. CSOs urge global cooperation for equitable vaccine access, highlighting the devastating effects of vaccine inequity during COVID-19. Uganda's health ministry implements response plans, designates Entebbe Hospital as evacuation center, and launches public health campaigns. Uganda set to receive 100,000 mpox vaccine doses through Africa CDC.

First doses of mpox vaccine reach Congo, but 3 million doses are needed to curb outbreaks. WHO declared mpox a global health emergency, and 380,000 doses have been promised by Western partners. Congo has reported over 4,900 cases and 629 deaths since 2024.